Misoprostol Vaginal Insert in Labor Induction: A Cost-Consequences Model for 5 European Countries-An Economic Evaluation Supported with Literature Review and Retrospective Data Collection.

Introduction: The present study aimed to assess the costs and consequences of using an innovative medical technology, misoprostol vaginal insert (MVI), for the induction of labor (IOL), in place of alternative technologies used as a standard of care.

Methods: This was a retrospective study on cost and resource utilization connected with economic model development. Target population were women with an unfavorable cervix, from 36 weeks of gestation, for whom IOL is clinically indicated.

[Roxithromycin (Rulid) in treatment of Chlamydia trachomatis genital infections in women].

New macrolide antibiotic, roxithromycin (erythromycin--like group), was tested in treatment of chlamydial genital infection in women. In comparison with doxycycline, roxithromycin showed higher clinical efficiency with fewer sides effects.

[The role of estrogens in bone metabolism in women after menopause].

Mechanism of estrogens effect on bone metabolism in relation to postmenopausal period is discussed. An emphasis is on multiple effects of estrogens as both systemic and local factors. A role of progesterone and other gestagens in the process of bone remodelling is also stressed.

[Infection with chlamydia trachomatis among women with infertility treatment].

68 women with sterility treatment were tested. Among 13 of them (20%) presence of chlamydial antibodies was found. Hormonal profile was estimated.

[Urinary steroid profiling in postmenopausal women (preliminary notes)].

Urinary steroid profiling by means of Capillary gas chromatography in postmenopausal women was detected. Glass capillary columns, OV-1, were used. Our results show that there is a rise of extraction of etiocholanolone (ET) in case of postmenopausal women in compare with androsterone (AN).